팔로우
Sara Tomei
Sara Tomei
A/Director - Integrated Genomics Services; Manager - Omics Core and Biorepository at Sidra Medicine
sidra.org의 이메일 확인됨
제목
인용
인용
연도
Epigenetic silencing of microRNA-149 in cancer-associated fibroblasts mediates prostaglandin E2/interleukin-6 signaling in the tumor microenvironment
P Li, JX Shan, XH Chen, D Zhang, LP Su, XY Huang, BQ Yu, QM Zhi, ...
Cell research 25 (5), 588-603, 2015
1692015
CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2
D Bedognetti, TL Spivey, Y Zhao, L Uccellini, S Tomei, ME Dudley, ...
British journal of cancer 109 (9), 2412-2423, 2013
1472013
Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysis
W Hendrickx, I Simeone, S Anjum, Y Mokrab, F Bertucci, P Finetti, ...
Oncoimmunology 6 (2), e1253654, 2017
1452017
Molecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patients
ML Ascierto, MO Idowu, Y Zhao, H Khalak, KK Payne, XY Wang, ...
Journal of translational medicine 11, 1-11, 2013
1152013
Future perspectives in melanoma research: Meeting report from the “Melanoma Bridge”. Napoli, December 1st–4th 2015
PA Ascierto, S Agarwala, G Botti, A Cesano, G Ciliberto, MA Davies, ...
Journal of translational medicine 14, 1-25, 2016
952016
IRF-1 responsiveness to IFN-γ predicts different cancer immune phenotypes
D Murtas, D Maric, V De Giorgi, J Reinboth, A Worschech, P Fetsch, ...
British journal of cancer 109 (1), 76-82, 2013
672013
Cutaneous melanoma classification: the importance of high-throughput genomic technologies
C Scatena, D Murtas, S Tomei
Frontiers in oncology 11, 635488, 2021
592021
Detection of the BRAF V600E mutation in fine needle aspiration cytology of thyroid papillary microcarcinoma cells selected by manual macrodissection: an easy tool to improve …
I Marchetti, G Iervasi, CM Mazzanti, F Lessi, S Tomei, AG Naccarato, ...
Thyroid 22 (3), 292-298, 2012
592012
The combination of four molecular markers improves thyroid cancer cytologic diagnosis and patient management
F Panebianco, C Mazzanti, S Tomei, P Aretini, S Franceschi, F Lessi, ...
Bmc Cancer 15, 1-11, 2015
572015
Melanoma NOS1 expression promotes dysfunctional IFN signaling
Q Liu, S Tomei, ML Ascierto, V De Giorgi, D Bedognetti, C Dai, L Uccellini, ...
The Journal of clinical investigation 124 (5), 2147-2159, 2014
492014
VHL and HIF-1α: gene variations and prognosis in early-stage clear cell renal cell carcinoma
F Lessi, CM Mazzanti, S Tomei, C Di Cristofano, A Minervini, M Menicagli, ...
Medical Oncology 31, 1-7, 2014
432014
IRF5 gene polymorphisms in melanoma
L Uccellini, V De Giorgi, Y Zhao, B Tumaini, N Erdenebileg, ME Dudley, ...
Journal of translational medicine 10, 1-8, 2012
402012
The immune-related role of BRAF in melanoma
S Tomei, D Bedognetti, V De Giorgi, M Sommariva, S Civini, J Reinboth, ...
Molecular oncology 9 (1), 93-104, 2015
352015
Evaluation of methods for the extraction of microbial DNA from vaginal swabs used for microbiome studies
V Mattei, S Murugesan, M Al Hashmi, R Mathew, N James, P Singh, ...
Frontiers in Cellular and Infection Microbiology 9, 197, 2019
342019
SITC/iSBTc Cancer Immunotherapy Biomarkers Resource Document: online resources and useful tools-a compass in the land of biomarker discovery
D Bedognetti, JM Balwit, E Wang, ML Disis, CM Britten, LG Delogu, ...
Journal of translational medicine 9, 1-21, 2011
342011
The stable traits of melanoma genetics: an alternate approach to target discovery
TL Spivey, V De Giorgi, Y Zhao, D Bedognetti, Z Pos, Q Liu, S Tomei, ...
BMC genomics 13, 1-11, 2012
312012
Temple-baraitser syndrome and zimmermann-laband syndrome: one clinical entity?
A Mégarbané, R Al-Ali, N Choucair, M Lek, E Wang, M Ladjimi, CM Rose, ...
BMC medical genetics 17, 1-11, 2016
292016
Molecular characterization of low grade and high grade bladder cancer
A Apollo, V Ortenzi, C Scatena, K Zavaglia, P Aretini, F Lessi, ...
PLoS One 14 (1), e0210635, 2019
282019
A molecular computational model improves the preoperative diagnosis of thyroid nodules
S Tomei, I Marchetti, K Zavaglia, F Lessi, A Apollo, P Aretini, G Di Coscio, ...
BMC cancer 12, 1-10, 2012
282012
c-KIT receptor expression is strictly associated with the biological behaviour of thyroid nodules
S Tomei, C Mazzanti, I Marchetti, L Rossi, K Zavaglia, F Lessi, A Apollo, ...
Journal of translational medicine 10, 1-9, 2012
272012
현재 시스템이 작동되지 않습니다. 나중에 다시 시도해 주세요.
학술자료 1–20